Assessment of CRC patient survival also revealed that overexpression of MEK5 was significantly correlated with short disease-free survival (P < 0.001, Table 3 and Fig. 3-a) and poor overall survival (P = 0.012, Table 4 and Fig. 3-b). Here, MAP2K5 is linked to colorectal carcinoma.